Main Line Health specialists use the knowledge gained from research studies and clinical trials to assess and create treatment options that work best for your needs. Therapies for these disorders are designed to optimize health and improve quality of life. An individualized regimen is developed for each patient and modified as necessary to achieve treatment goals and the needs of each person. Once a diagnosis has been made, therapy will probably be needed life-long.
The goal of Immunoglobulin (Ig) therapy for antibody disorders is to replace the antibodies your body cannot make for itself, provide protection from infections, and reduce the frequency and severity of any possible infection.
Blood plasma that contains immunoglobulins, or antibodies. People who are unable to produce enough Ig (antibodies), such as patients with XLA and CVID may benefit from replacement therapy with Ig therapy. This treatment can be given by IV (through a vein) or subcutaneously (under the skin):
- Ig is prepared from the purified pooled plasma from a large number of normal individuals who have been carefully screened to make sure they are healthy and do not have any infectious diseases, according to the strict rules of the American Association of Blood Banks and the U.S. Food and Drug Administration (FDA).